Portfolio company
DC Prime
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops allogeneic dendritic cell-based vaccines for patients with haematological malignancies and solid tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Infinitopes
This biotechnology company develops precision therapeutic cancer vaccines and antigen discovery platforms for healthcare providers and patients with solid tumours.
PanCancerT
This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.
Primmune Therapeutics Inc
This clinical-stage biotechnology company develops orally administered small molecule immunotherapies to treat patients with solid tumours and viral infections.
Revealis Biotherapeutics
This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.
Geneos Therapeutics
This company develops personalised DNA-based therapeutic cancer vaccines and immunotherapies for patients with advanced hepatocellular carcinoma and other solid tumours.
Profound Bio
This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.
Clinical stage immunotherapy company
This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.
Adcendo
This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.
